TheBigHunter
Nuovo Utente
- Registrato
- 8/12/20
- Messaggi
- 575
- Punti reazioni
- 91
Occhio after
Palese pompata... Però non sono sicuro di uscire subito se fa gap up domani... Teoricamente ne hanno un bel po' da piazzare
...inizia effettivamente la pompata.....in after +20% a 2,75 con 2.4 Milioni di pezzi scambiati su Upgrade di BAIRD con TP di 9$
VistaGen surges 17% post-market after Baird calls stock 'significantly undervalued'
May 19, 2021 4:48 PM ETVistaGen Therapeutics, Inc. (VTGN)By: Jonathan M Block, SA News Editor1 Comment
Baird has initiated shares of VistaGen Therapeutics (NASDAQ:VTGN) with an outperform rating, calling the stock "significantly undervalued" and "a big outperformer over the next year."
Analyst Brian Skorney has a $9 price target, implying a 291% return from today's close.
Skorney highlights the potential of its phase 3 lead candidate, PH94B, a synthetic pherine nasal spray for anxiety, as having a very large commercial opportunity.
The company says PH94B's mechanism of action is fundamentally different from benzodiazepines and other anti-anxiety medicines, with fewer side effects and safety concerns.
VistaGen shares are up 17% to $2.69 in after-hours trading.